PTC Therapeutics and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial

Please take some time to read this important announcement:

PTC Therapeutics and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial of Ataluren for Nonsense Mutation Duchenne/Becker Muscular Dystrophy

*

AVI BioPharma Receives Grants of $500,000 from CureDuchenne and Foundation to Eradicate Duchenne

This is a very exciting article. For anyone interested in learning about the strides being made to find a cure for Duchenne muscular dystrophy (DMD), please take some time to read it:

AVI BioPharma Receives Grants of $500,000 from CureDuchenne and Foundation to Eradicate Duchenne

*

UCLA Hopes for Duchenne Muscular Dystrophy Clinic

At CureDuchenne, we’re very pleased to announce the plans for a Duchenne muscular dystrophy (DMD) specific clinic at UCLA. Not too long ago, CureDuchenne committed $200,000 towards the clinic and research facility.

This is great news for parents of sons with DMD on the West Coast to have such a facility so close. We’re also pleased to have Carrie Miceli, Ph.D and Stanley Nelson, M.D., Ph.D. (both of whom serve as Scientific Advisors for CureDuchenne) leading the way at UCLA.

We have our annual Dealing For Duchenne Poker Tournament in Los Angeles coming up on June 12th at the Petersen Automotive museum. The event, led by Amy and Chris Martin, is sure to make for a great night for an even greater cause.

Read more about the Duchenne clinic at UCLA here:

UCLA hopes for Duchenne muscular dystrophy clinic

*

Next Page »